Skip to main content

Table 5 Univariate analyses in HBsAg-positive and -negative DLBCL patients

From: Clinicopathological and prognostic features of hepatitis B virus-associated diffuse large B-cell lymphoma: a single-center retrospective study in China

Characteristics

HBsAg-positive DLBCL patients

HBsAg- negative DLBCL patients

N (total = 127)

Log-rank P-value

N (total = 293)

Log-rank P value

Sex

    

 Male

79

0.5748

158

0.6699

 Female

48

 

135

 

Age

    

 > 60

22

0.0377

97

< 0.0001

 ≤ 60

105

 

196

 

Ann Arbor stage

    

 I

18

0.0002

48

< 0.0001

 II

37

 

113

 

 III

34

 

44

 

 IV

38

 

88

 

B symptoms

    

 Present

28

0.0003

76

0.697

 Absent

99

 

217

 

Elevated LDH

    

 Present

67

0.0487

135

< 0.0001

 Absent

56

 

158

 

 Unknown

4

 

–

 

Treatment with rituximab

    

 Yes

60

0.0152

143

0.002

 No

67

 

150

 

Spleen involvement

    

 Yes

28

0.034

19

0.002

 No

99

 

274

 

Bcl-2&Myc positive

    

 Yes

34

0.048

57

0.037

 No

22

 

59

 

 Unknown

71

 

177

 

Cell of origin

    

 GCB

47

0.124

107

0.103

 Non-GCB

80

 

186

 

HBV DNA copies

    

 < 1000 copies/ml

51

0.536

–

–

 > 1000 copies/ml

69

   

 Unknown

7

   

HBeAg

    

 Positive

25

0.534

–

–

 Negative

95

   

 Unknown

7

  Â